Tevogen, Inc. (TVGN)
5.905
-0.24
(-3.83%)
USD |
NASDAQ |
Nov 19, 16:00
5.905
0.00 (0.00%)
After-Hours: 20:00
Tevogen Shareholders Equity (Quarterly) : -11.29M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -11.29M |
| June 30, 2026 | -8.889M |
| March 31, 2026 | -9.842M |
| December 31, 2025 | -8.235M |
| September 30, 2025 | -7.824M |
| June 30, 2025 | -9.485M |
| March 31, 2025 | -7.720M |
| December 31, 2024 | -6.674M |
| September 30, 2024 | -6.190M |
| June 30, 2024 | -7.634M |
| March 31, 2024 | -5.803M |
| Date | Value |
|---|---|
| December 31, 2023 | -94.43M |
| September 30, 2023 | 9.847M |
| June 30, 2023 | 10.13M |
| March 31, 2023 | 10.05M |
| December 31, 2022 | 342.08M |
| September 30, 2022 | 339.47M |
| June 30, 2022 | 337.85M |
| March 31, 2022 | 337.65M |
| December 31, 2021 | 337.67M |
| September 30, 2021 | 0.0136M |
| June 30, 2021 | 0.0137M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -7.503M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.529B |
| Anixa Biosciences, Inc. | 14.47M |
| Vicapsys Life Sciences, Inc. | -3.549M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.514M |
| Total Liabilities (Quarterly) | 14.81M |
| Debt to Equity Ratio | -0.9219 |
| Current Ratio | 0.132 |
| Net Debt Paydown Yield | -0.55% |